Dong Li

Dr. Dong Li


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2024 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
RJRuigang Jia
Ruigang Jia
DLDong Li
Dong Li
PHPeng He
Peng He
XWXin-Qiang Wang
Xin-Qiang Wang
YZYunpeng Zhang
Yunpeng Zhang
JTJiwei Tian
Jiwei Tian
Background: No studies have evaluated the impact of the cement distribution as classified on the basis of the fracture bone marrow edema area (FBMEA) in magnetic resonance imaging (MRI) on the efficacy of percutaneous vertebral augmentation (PVA) for acute osteoporotic vertebral fractures. Methods: The clinical data of patients with acute, painful, single-level thoracolumbar osteoporotic fractures were retrospectively analyzed. The bone cement distribution on the postoperative radiograph was divided into 4 types according to the distribution of the FBMEA on the preoperative MRI. The primary outcomes were the postoperative visual analog scale (VAS) for pain and Oswestry Disability Index (ODI) scores. Cement leakage, adjacent vertebral fractures (an important concern in complications after vertebroplasty and a subset of new fractures), and recollapse of the treated vertebra were also evaluated. Results: A total of 128 patients, 80.5% of whom were female, were included and had follow-up for 24 months. The mean patient age (and standard deviation) was 74.2 ± 8.6 years. The cement distribution was classified as Type I in 18 patients, Type II in 26, Type III in 46, and Type IV in 38. At the primary time point (6 months), there was a significant difference in the ODI score favoring the Type-III and Type-IV groups compared with the Type-I and Type-II groups (adjusted 95% confidence interval [CI]: Type I versus Type II, −2.40 to 4.50; Type I versus Type III, 1.35 to 7.63; Type I versus Type IV, 1.27 to 7.92; Type II versus Type III, 0.67 to 6.21; Type II versus Type IV, 0.63 to 6.46; adjusted p < 0.0083), whereas no significant differences were found between the 4 groups in the VAS pain score. The Type-II and Type-IV groups had a higher incidence of cement leakage, and the Type-III and Type-IV groups had a lower incidence of vertebral recollapse. Conclusions: An adequate distribution of bone cement is advantageous for functional improvement, short-term pain relief, and a lower rate of vertebral recollapse. The FBMEA appears to be a feasible reference marker for evaluating the performance of the PVA procedure. Level of Evidence: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.

19 November 2025 in Materials Today Bio
Verified
Journal Article
Open access
JFJiahao Fu
Jiahao Fu
HLHai Lan
Hai Lan
LLLikun Liu
Likun Liu
LZLingling Zou
Lingling Zou
XHXiang Huan
Xiang Huan
DLDong Li
Dong Li
Addressing two major challenges in the field of bone implants: bacterial infection and delayed bone fusion, this study draws inspiration from the beehive structure to develop an adaptive enzyme-responsive hydrogel composite scaffold. The scaffold composed of an intermittently 3D low-temperature deposition printing honeycomb-shaped Poly(lactic-co-glycolic acid)/β-tricalcium phosphate icaritin (PTI) outer layer, maintaining the mechanical strength(elastic modulus ∼0.8 MPa) and osteogenic activity required for bone defect repair. Its core encapsulates hyaluronic acid (HA) hydrogel loaded with vancomycin(Van), serving as an intelligent "enzyme-responsive" unit. This core design utilizes bacterial-secreted hyaluronidase (HAase) at the infection site as a trigger signal, enabling on-demand, intelligent release of Van akin to the beehive sensing threats, while degrading slowly in the absence of infection, thereby achieving precise prevention of post-implantation infections. In vitro and in vivo results confirmed the scaffold's excellent dynamic responsive antibacterial performance, effectively eliminating target pathogens. Simultaneously, the hydrogel inner layer exhibited outstanding biocompatibility, synergistically promoting the proliferation, migration, and in vitro osteogenic differentiation of bone marrow mesenchymal stem cells(BMSCs). In a rabbit tibial defect infection model, the scaffold successfully mimicked the beehive's active defense mechanism, effectively suppressing Methicillin-resistant Staphylococcus aureus (MRSA) infection within 14 days post-implantation, achieveing simultaneous and ideal bone repair outcomes.

28 September 2021 in World Chinese Journal of Digestology
Verified
Journal Article
Open access
CSChen-ZhuoYa Sheng
Chen-ZhuoYa Sheng
GYGen-Xin Yao
Gen-Xin Yao
XZXin-Rong Zhang
Xin-Rong Zhang
DLDong Li
Dong Li
原发性肝细胞癌(hepatocellular carcinoma, HCC)作为一种富血供肿瘤, 其血流灌注变化贯穿于肿瘤的整个病理学过程. 超声造影(contrast-enhanced ultrasound, CEUS)通过分析肿瘤组织的血流灌注变化, 能客观反映其血管生成状态, 继而间接反映其病理生物学特征, 有着重要临床意义. 探讨超声造影灌注参数与原发性肝细胞癌酪氨酸蛋白激酶受体B4(ephrin type-B receptor 4, EphB4)表达水平的相关性. 选取在我院行手术切除治疗的52例HCC患者作为研究对象. 所有患者术前1周内行CEUS检查, 测定肝癌组织以及癌旁组织的血流灌注参数: 峰值强度(maximum intensity, IMAX)、达峰时间(time to peak, TTP)、流出时间(washout time, WT). 术后将肝癌组织以及癌旁组织标本送病理检测, 测定各组织EphB4表达水平及微血管密度(microvessel density, MVD). 肝癌组织IMAX明显高于癌旁组织, 差异有统计学意义(P<0.05); 肝癌组织TTP、WT明显短于癌旁组织, 差异有统计学意义(P<0.05); 肝癌组织EphB4表达水平及MVD明显高于癌旁组织, 差异有统计学意义(P<0.05); 肝癌组织EphB4表达水平与IMAX 呈正相关(r = 0.862, P<0.05), 与TTP、WT呈负相关(r = -0.765, r = -0.781, 均P<0.05). CEUS能定量评估HCC微循环血流状态, 其灌注参数与EphB4表达水平有一定相关性, 可为临床无创性评估EphB4表达水平提供参考.